ELITE PHARMACEUTICALS INC /NV/ Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Elite Pharmaceuticals Inc /Nv/ quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • Elite Pharmaceuticals Inc /Nv/ Net Cash Provided by (Used in) Financing Activities for the quarter ending June 30, 2024 was -$175K, a 104% decline year-over-year.
  • Elite Pharmaceuticals Inc /Nv/ annual Net Cash Provided by (Used in) Financing Activities for 2023 was $3.39M, a 98.9% increase from 2022.
  • Elite Pharmaceuticals Inc /Nv/ annual Net Cash Provided by (Used in) Financing Activities for 2022 was $1.7M.
  • Elite Pharmaceuticals Inc /Nv/ annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$667K, a 23.3% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $3.39M +$1.68M +98.9% Apr 1, 2023 Mar 31, 2024 10-K 2024-07-01
2022 $1.7M +$2.37M Apr 1, 2022 Mar 31, 2023 10-K 2024-07-01
2021 -$667K +$203K +23.3% Apr 1, 2021 Mar 31, 2022 10-K 2023-06-29
2020 -$870K -$1.56M -226% Apr 1, 2020 Mar 31, 2021 10-K 2022-06-29
2019 $690K -$877K -56% Apr 1, 2019 Mar 31, 2020 10-K 2021-06-14
2018 $1.57M -$104K -6.24% Apr 1, 2018 Mar 31, 2019 10-K 2020-06-30
2017 $1.67M -$6.4M -79.3% Apr 1, 2017 Mar 31, 2018 10-K 2019-06-21
2016 $8.07M -$691K -7.89% Apr 1, 2016 Mar 31, 2017 10-K 2018-06-14
2015 $8.76M Apr 1, 2015 Mar 31, 2016 10-K 2018-06-14
2012 $1.84M +$1.94M Apr 1, 2012 Mar 31, 2013 10-K 2013-06-21
2011 -$106K -$1.15M -110% Apr 1, 2011 Mar 31, 2012 10-K 2013-06-21
2010 $1.05M Apr 1, 2010 Mar 31, 2011 10-K 2012-06-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.